We’re delighted to announce that Ulrik Berthelsen has been appointed CEO of XO CARE A/S, effective 15 August 2022. Ulrik has extensive global experience in the MedTech industry and is the perfect match to accelerate the company’s growth and fulfill our ambition of radically expanding our brand and business.
Ulrik has a proven track record in creating business growth and profitability in companies like Atos Medical and Coloplast. The results speak for themselves, and we are confident that his professional skills and inspiring personality will enable us to strengthen and grow our business.
Ulrik’s appointment is a consequence of Kim Sørensen’s desire to devote himself fully to his role as Chief Designer. Kim continues to be part of XO’s Board of Directors and remains a key member of our company.
Ulrik Berthelsen bio:
- 15 years of experience from leading global companies in the MedTech industry
- Has been posted in the USA, Italy, Great Britain, Sweden and Denmark
- Extensive experience in developing and leading successful teams in growth companies
- Chief Commercialization & Innovation Officer and before that SVP sales at Atos Medical, which was sold to Coloplast at the beginning of 2022 as one of the largest acquisitions within MedTech in the Nordic region ever
- Previously held several senior positions at Coloplast and worked in the consulting industry at McKinsey & Co.